Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-Risk Neuroblastoma”

211 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 211 results

Testing effectiveness (Phase 2)Looking for participantsNCT02605421
What this trial is testing

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Study completedNCT01619865
What this trial is testing

Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors

Who this might be right for
Neuroendocrine TumorsCarcinoid TumorsNeuroblastoma+1 more
Sue O'Dorisio 223
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Testing effectiveness (Phase 2)Looking for participantsNCT05135975
What this trial is testing

Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Who this might be right for
NeuroblastomaSarcoma
Nationwide Children's Hospital 86
Early research (Phase 1)Study completedNCT00885326
What this trial is testing

N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 29
Not applicableUnknownNCT00939965
What this trial is testing

Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group 75
Not applicableActive Not RecruitingNCT07278674
What this trial is testing

Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma（CSHEIN）

Who this might be right for
High Risk Neuroblastoma
Shanghai Children's Hospital 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT06047535
What this trial is testing

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.

Who this might be right for
Neuroblastoma
SciClone Pharmaceuticals 62
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00186849
What this trial is testing

Therapy for Children With Advanced Stage High Risk Neuroblastoma

Who this might be right for
Neuroblastoma
St. Jude Children's Research Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT04909515
What this trial is testing

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission.

Who this might be right for
Neuroblastoma
Y-mAbs Therapeutics
Testing effectiveness (Phase 2)Ended earlyNCT01440283
What this trial is testing

A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) in High Risk Abdominal Neuroblastoma

Who this might be right for
Abdominal Neuroblastoma
St. Jude Children's Research Hospital 14
Testing effectiveness (Phase 2)Study completedNCT00276679
What this trial is testing

Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group
Not applicableStudy completedNCT00293384
What this trial is testing

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Barbara Ann Karmanos Cancer Institute 40
Testing effectiveness (Phase 2)Looking for participantsNCT06803875
What this trial is testing

Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaHigh-risk Neuroblastoma
Roberto Chiarle 42
Early research (Phase 1)Looking for participantsNCT05272371
What this trial is testing

Immunotherapy With Dinutuximab Beta in Combination With Chemotherapy for the Treatment of Patients With Primary Neuroblastoma Refractory to Standard Therapy and With Relapsed or Progressive Disease

Who this might be right for
High-Risk Neuroblastoma
Jagiellonian University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04385277
What this trial is testing

Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)

Who this might be right for
Ganglioneuroblastoma, NodularNeuroblastoma
Children's Oncology Group 41
Not applicableStudy completedNCT01526603
What this trial is testing

High Dose Chemotherapy and Autologous Transplant for Neuroblastoma

Who this might be right for
Neuroblastoma
Masonic Cancer Center, University of Minnesota 13
Testing effectiveness (Phase 2)UnknownNCT01807468
What this trial is testing

Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors

Who this might be right for
NeuroblastomaEwing SarcomaRhabdomyosarcoma+2 more
Samsung Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT01183416
What this trial is testing

High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Myeloablative Therapy and Autologous Stem-Cell Transplantation

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 4
Load More Results